Previous Nominations of
SFS Team Recognition Award - Second Edition
The investment in Moodify
The investment in Moodify
The IQOS preheating malodor is one of the most relevant reasons invoked by consumers not to switch to IQOS. In a pursue to delight consumers, the investment in Moodify (a company developing advanced olfactory sense technologies) is a fine example of breaking internal silos and on how collaboration between different functions (Product and SFS) can potentially lead to a great impact.
The Product and SFS cross-functional team performed above and beyond, negotiating an Investment Agreement and a Services Agreement in parallel, tightly aligning positions. Thanks to that, the first Co-Pilot between Moodify and PMI was a success, addressing the IQOS preheating malodor, with more to expect in the near future.
In recognition of the potential increase in revenue and better customer experience, I am pleased to nominate the cross-functional team for the SFS Co-Pilot Team Award.
Nominator: Waynn Wu, VP Investments and PMEP
Members
Project Story
PM Equity Partner (PMEP) is the Venture Capital arm of PMI, supporting the organization by introducing and investing in companies with potential to steer innovation through partnerships and co-development in the areas of RRP, Inhalable Therapeutics, Consumer Health, and Sustainability.
PM Equity Partner is a strong contributor to PMI’s innovative product portfolio. One recent example is the investment in Moodify, an Israeli start-up that leverages olfactory sense to improve performance and wellbeing. The company is developing a cutting-edge malodor solution based on a unique AI technology that can eliminate the perception of unpleasant odors - like what noise cancellation does for audio. In collaboration with PMI’s Product function, Moodify’s solution has shown the potential to address IQOS preheating malodor, which is one of the top 5 reasons invoked by consumers not to switch to IQOS.
PM Equity Partner invested in Moodify in Q2 2022 to accelerate the development of its technology. The first Co-Pilot between Moodify and PMI’s Product function has led to promising results. We believe that solving the preheating malodor will significantly impact PMI’s revenues while helping millions of consumers switch to better, smoke free options.
Beside the malodor control project, the investment in Moodify opened additional opportunities for the Product function to better correlate aroma perception & impact on consumers:
- Reformulation & Scent design: building on Moodify databases and using AI to design formulation tools to achieve desired flavor perception.
- Understanding satisfaction: Strengthen PMI’s fundamental understanding of the role of aroma into product satisfaction & acceptance.
Moodify was introduced to PMI’s Product function in 2020 by PM Equity Partner. We are convinced that the recent investment in Moodify will enhance PMI’s leadership position towards a smoke free world.
Previous Nominations of
SFS Team Recognition Award - First Edition
The investment in Moodify
The investment in Moodify
The IQOS preheating malodor is one of the most relevant reasons invoked by consumers not to switch to IQOS. In a pursue to delight consumers, the investment in Moodify (a company developing advanced olfactory sense technologies) is a fine example of breaking internal silos and on how collaboration between different functions (Product and SFS) can potentially lead to a great impact.
The Product and SFS cross-functional team performed above and beyond, negotiating an Investment Agreement and a Services Agreement in parallel, tightly aligning positions. Thanks to that, the first Co-Pilot between Moodify and PMI was a success, addressing the IQOS preheating malodor, with more to expect in the near future.
In recognition of the potential increase in revenue and better customer experience, I am pleased to nominate the cross-functional team for the SFS Co-Pilot Team Award.
Nominator: Waynn Wu, VP Investments and PMEP
Members
Project Story
PM Equity Partner (PMEP) is the Venture Capital arm of PMI, supporting the organization by introducing and investing in companies with potential to steer innovation through partnerships and co-development in the areas of RRP, Inhalable Therapeutics, Consumer Health, and Sustainability.
PM Equity Partner is a strong contributor to PMI’s innovative product portfolio. One recent example is the investment in Moodify, an Israeli start-up that leverages olfactory sense to improve performance and wellbeing. The company is developing a cutting-edge malodor solution based on a unique AI technology that can eliminate the perception of unpleasant odors - like what noise cancellation does for audio. In collaboration with PMI’s Product function, Moodify’s solution has shown the potential to address IQOS preheating malodor, which is one of the top 5 reasons invoked by consumers not to switch to IQOS.
PM Equity Partner invested in Moodify in Q2 2022 to accelerate the development of its technology. The first Co-Pilot between Moodify and PMI’s Product function has led to promising results. We believe that solving the preheating malodor will significantly impact PMI’s revenues while helping millions of consumers switch to better, smoke free options.
Beside the malodor control project, the investment in Moodify opened additional opportunities for the Product function to better correlate aroma perception & impact on consumers:
- Reformulation & Scent design: building on Moodify databases and using AI to design formulation tools to achieve desired flavor perception.
- Understanding satisfaction: Strengthen PMI’s fundamental understanding of the role of aroma into product satisfaction & acceptance.
Moodify was introduced to PMI’s Product function in 2020 by PM Equity Partner. We are convinced that the recent investment in Moodify will enhance PMI’s leadership position towards a smoke free world.
© 2021 - Powered by IT Global Communications